{ "cik": 875320, "cik_padded": "0000875320", "entityName": "VERTEX PHARMACEUTICALS INC / MA", "fiscal_years": [ { "accn": "0000875320-26-000056", "filed": "2026-02-13", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 2017400000.0, "capex": 437600000.0, "cash": 5084800000.0, "eps_diluted": 15.32, "free_cash_flow": 3193800000.0, "net_income": 3953200000.0, "operating_cash_flow": 3631400000.0, "operating_income": 4173300000.0, "revenue": 12001300000.0, "stockholders_equity": 18665800000.0, "total_assets": 25643000000.0, "total_liabilities": 6977200000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.37379592623943253, "net_margin": 0.3293976485880697, "operating_margin": 0.3477373284560839, "revenue_growth_yoy": 0.0890373045616646, "roa_avg2y": 0.1641142306782187, "roa_period_end": 0.154162929454432, "roe_avg2y": 0.22541154199239352, "roe_period_end": 0.21178840446163572 } }, { "accn": "0000875320-26-000056", "filed": "2026-02-13", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 1177100000.0, "capex": 297700000.0, "cash": 4569600000.0, "eps_diluted": -2.08, "free_cash_flow": -790300000.0, "net_income": -535600000.0, "operating_cash_flow": -492600000.0, "operating_income": -232900000.0, "revenue": 11020100000.0, "stockholders_equity": 16409600000.0, "total_assets": 22533200000.0, "total_liabilities": 6123600000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3731718018720749, "net_margin": -0.04860209979945736, "operating_margin": -0.021134109490839464, "revenue_growth_yoy": 0.11661532849673732, "roa_avg2y": -0.02366591992647481, "roa_period_end": -0.023769371416398913, "roe_avg2y": -0.03151515151515152, "roe_period_end": -0.032639430577223086 } }, { "accn": "0000875320-26-000056", "filed": "2026-02-13", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 427600000.0, "capex": 200400000.0, "cash": 10369100000.0, "eps_diluted": 13.89, "free_cash_flow": 3336900000.0, "net_income": 3619600000.0, "operating_cash_flow": 3537300000.0, "operating_income": 3832000000.0, "revenue": 9869200000.0, "stockholders_equity": 17580400000.0, "total_assets": 22730200000.0, "total_liabilities": 5149800000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.29292848854406045, "net_margin": 0.36675718396627893, "operating_margin": 0.388278685202448, "revenue_growth_yoy": 0.10508694727177041, "roa_avg2y": 0.1770793838717647, "roa_period_end": 0.15924188964461378, "roe_avg2y": 0.22986622466508536, "roe_period_end": 0.20588837569111054 } }, { "accn": "0000875320-26-000056", "filed": "2026-02-13", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 204700000.0, "cash": 10504000000.0, "eps_diluted": 12.82, "free_cash_flow": 3925200000.0, "net_income": 3322000000.0, "operating_cash_flow": 4129900000.0, "operating_income": 4307400000.0, "revenue": 8930700000.0, "stockholders_equity": 13912700000.0, "total_assets": 18150900000.0, "total_liabilities": 4238200000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3046281455073422, "net_margin": 0.3719753210834537, "operating_margin": 0.48231381638617354, "revenue_growth_yoy": 0.17906368821292776, "roa_avg2y": 0.2103636720555735, "roa_period_end": 0.1830212275975296, "roe_avg2y": 0.2766869198382523, "roe_period_end": 0.23877464474904225 } }, { "accn": "0000875320-25-000053", "filed": "2025-02-13", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 1425400000.0, "capex": 235000000.0, "cash": 6795000000.0, "eps_diluted": 9.01, "free_cash_flow": 2408500000.0, "net_income": 2342100000.0, "operating_cash_flow": 2643500000.0, "operating_income": 2782100000.0, "revenue": 7574400000.0, "stockholders_equity": 10100000000.0, "total_assets": 13432500000.0, "total_liabilities": 3332500000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.32995049504950497, "net_margin": 0.30921261089987323, "operating_margin": 0.36730302070130966, "revenue_growth_yoy": 0.22055529593760576, "roa_avg2y": 0.18599683135921982, "roa_period_end": 0.1743606923506421, "roe_avg2y": 0.2493346392147678, "roe_period_end": 0.2318910891089109 } }, { "accn": "0000875320-24-000062", "filed": "2024-02-15", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 539100000.0, "capex": 259800000.0, "cash": 5988200000.0, "eps_diluted": 10.29, "free_cash_flow": 2993700000.0, "net_income": 2711700000.0, "operating_cash_flow": 3253500000.0, "operating_income": 2856300000.0, "revenue": 6205700000.0, "stockholders_equity": 8686800000.0, "total_assets": 11751800000.0, "total_liabilities": 3065000000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.35283418520053417, "net_margin": 0.4369692379586509, "operating_margin": 0.4602703965708945, "revenue_growth_yoy": 0.49075141731526856, "roa_avg2y": 0.2702206473108352, "roa_period_end": 0.23074763015027486, "roe_avg2y": 0.36714053614947195, "roe_period_end": 0.3121632822213013 } }, { "accn": "0000875320-23-000007", "filed": "2023-02-10", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 186000000.0, "capex": 75400000.0, "cash": 3109300000.0, "eps_diluted": 4.51, "free_cash_flow": 1493900000.0, "net_income": 1176800000.0, "operating_cash_flow": 1569300000.0, "operating_income": 1197500000.0, "revenue": 4162800000.0, "stockholders_equity": 6085200000.0, "total_assets": 8318465000.0, "total_liabilities": 2233221000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3669922106093473, "net_margin": 0.2826943403478428, "operating_margin": 0.28766695493417893, "revenue_growth_yoy": 0.36592863163994455, "roa_avg2y": 0.16159992716468272, "roa_period_end": 0.14146840793343485, "roe_avg2y": 0.22371772936390252, "roe_period_end": 0.19338723460198515 } }, { "accn": "0000875320-22-000007", "filed": "2022-02-09", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 350043000.0, "capex": 95449000.0, "cash": 2650100000.0, "eps_diluted": 8.09, "free_cash_flow": 1174837000.0, "net_income": 2096896000.0, "operating_cash_flow": 1270286000.0, "operating_income": 635150000.0, "revenue": 3047597000.0, "stockholders_equity": 4435200000.0, "total_assets": 6245898000.0, "total_liabilities": 1810695000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.4082555465367965, "net_margin": 0.6880489776043224, "operating_margin": 0.2084101014668278, "revenue_growth_yoy": 0.22459749293995304, "roa_avg2y": 0.4282914307236421, "roa_period_end": 0.3357237021802149, "roe_avg2y": 0.6488142617499763, "roe_period_end": 0.4727849927849928 } }, { "accn": "0000875320-21-000006", "filed": "2021-02-11", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 99421000.0, "cash": 1665412000.0, "eps_diluted": 1.04, "free_cash_flow": 745521000.0, "net_income": 263484000.0, "operating_cash_flow": 844942000.0, "operating_income": 123243000.0, "revenue": 2488652000.0, "stockholders_equity": 2028579000.0, "total_assets": 3546014000.0, "total_liabilities": 1503708000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.7412617403611099, "net_margin": 0.10587418409645061, "operating_margin": 0.04952199021799753, "revenue_growth_yoy": 0.4620406690961046, "roa_avg2y": 0.08179175485941596, "roa_period_end": 0.0743042751664263, "roe_avg2y": 0.16544469808590523, "roe_period_end": 0.12988599408748686 } }, { "accn": "0000875320-20-000007", "filed": "2020-02-13", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 56563000.0, "cash": 1183945000.0, "eps_diluted": -0.46, "free_cash_flow": 179540000.0, "net_income": -112052000.0, "operating_cash_flow": 236103000.0, "operating_income": 9936000.0, "revenue": 1702177000.0, "stockholders_equity": 1156582000.0, "total_assets": 2896787000.0, "total_liabilities": 1558596000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.3475879790624443, "net_margin": -0.06582864179224605, "operating_margin": 0.00583723079327238, "roa_period_end": -0.038681477098592335, "roe_period_end": -0.09688201960604609 } } ], "latest_filing": { "accn": "0000875320-26-000056", "filed": "2026-02-13", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000875320.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0000875320.json" }, "ticker": "VRTX" }